1. Introduction {#sec1}
===============

Cancer has emerged as a serious global threat. Chemotherapy is one of the most effective treatments for cancer. It is a systemic treatment, but at the same time, it often causes myelosuppression due to its toxicity to cells. Myelosuppression often first manifests as a decline in white blood cells, followed by a series of hematopoietic impairments [@bib1], [@bib2]. Its essence is the decrease of precursor blood cell activity, which affects the ability of hematopoietic stem cells to proliferate and differentiate [@bib3], [@bib4]. Myelosuppression can limit the progress of chemotherapy; severe myelosuppression also leads to secondary infections or bleeding, which in turn threatens the lives of patients [@bib5], [@bib6] Therefore, improving the symptoms of myelosuppression during the treatment of cancer has become the key to ensure the efficacy of chemotherapy.

Ginseng is the root of *Panax ginseng* Meyer. It has been used as a traditional Chinese medicine in China for more than 4,000 years. Total ginsenosides derived from ginseng possess various biological activities [@bib7]. Among the total ginsenosides, ginsenoside Re (Re) is regarded as the main active components. Modern medical research shows that Re plays an important role in resisting cancer [@bib8], improving immunity [@bib9], enhancing memory [@bib10], and improving cardiovascular system [@bib11]. Ginsenoside Rk~3~ (Rk~3~) is a secondary metabolite of Re. Previous experiments showed that Rk~3~ possesses anticancer [@bib12], immunomodulatory [@bib13], and anti--platelet-aggregating [@bib14] activities. Re is a kind of polar ginsenoside, whereas Rk~3~ is a kind of nonpolar ginsenoside. Rk~3~ can be obtained from Re by hydrolysis of the sugar moieties [@bib15]. Compared with polar ginsenosides, nonpolar ginsenosides are more easily absorbed and have better pharmacological activity due to its lower polarity [@bib15].

Based on the traditional efficacy of ginseng and previous studies, we speculated that Re and Rk~3~ can improve bone marrow hematopoietic function and can be used for the treatment of chemotherapy-induced myelosuppression. To validate the speculation and compare the two, we investigated the effects of Re and Rk~3~ on hematopoietic function of bone marrow, including peripheral blood, bone marrow nucleated cell (BMNC) counts, and thymus/spleen index in cyclophosphamide (CTX)-induced myelosuppression mice. The mechanism of action is explored at the cellular and molecular levels by detecting the proliferation and differentiation of hematopoietic progenitor cells, bone marrow cell cycle, cell growth factor content, and bone marrow cell apoptosis protein expression.

2. Materials and methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

Re and Rk~3~ were purchased from College of Fundamental Medical, Jilin University (Changchun, China). All standards were at least 98% pure, as confirmed by HPLC. HPLC-grade acetonitrile and methanol were purchased from Fisher (USA). Cyclophosphamide was obtained from Jiangsu Shengdi Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, China). Mouse G-CSF, erythropoietin (EPO), thrombopoietin (TPO), and interleukin-2 (IL-2) were supplied by novoprotein Scientific Inc. (Shanghai, China). We purchased enzyme-linked immunosorbent assay kits for mouse G-CSF, EPO, and TPO from R&D systems (Minneapolis, MN, USA). Rabbit monoclonal anti-bax, anti-bcl-2, and anti-caspase-3 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Propidium iodide used in current experiments was purchased from Tianjin Sungene Biotech Co., Ltd. (Tianjin, China). All other chemicals were of the highest grade from a commercial source.

2.2. Animals {#sec2.2}
------------

Male Balb/c mice with body weights ranging from 18 to 22 g were obtained from the Laboratory Animal Quality Testing Center of Jilin Province (Certificate No. SCXK-2016-0003) and maintained at controlled temperature (22 ± 2°C) and humidity (50% ± 10%) with a 12 h/12 h light/dark cycle. All efforts were made to minimize the pain of animals. The animal procedures were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and approved by the Animal Ethics Committee of China Academy of Chinese Medical Sciences.

After seven days of acclimatization, the mice were divided into seven groups (n = 10 per group): (1) normal control group (Normal), (2) CTX treatment group (Model), (3) CTX + rhG-CSF (Positive), (4) CTX + low-dose Re (Re-L), (5) CTX + high-dose Re (Re-H), (6) CTX + low-dose Rk~3~ (Rk~3~-L), and (7) CTX + high-dose Rk~3~ (Rk~3~-H).

The mice in Groups 2--7 were intraperitoneally (i.p.) injected with a dose of CTX (100 mg kg^−1^, 0.1 mL 10 g^−1^) for 3 days, and the normal group received an equal volume of saline. After CTX treatment for 24 hours, all the drug treatment groups (Groups 3--7) were i.p. injected with rhG-CSF (11.25 μg kg^−1^), Re (5 and 10 mg kg^−1^), or Rk~3~ (5 and 10 mg kg^−1^) for 7 days. The normal and model groups were administered an equivalent volume of saline water, once a day for 7 consecutive days.

2.3. Detection of peripheral blood cells {#sec2.3}
----------------------------------------

On Day 11, blood samples were collected from the eye socket vein, and white blood cells (WBCs), red blood cells (RBCs), hemoglobin (HGB), and platelets (PLTs) were counted using a cell counter. After the last drug administration, body weights of mice were measured. Blood samples were extracted from eyeballs and collected in test tubes with ethylenediaminetetraacetic acid for further analysis.

2.4. Determinations of thymus/spleen index and bone marrow nucleated cells {#sec2.4}
--------------------------------------------------------------------------

After blood samples were collected, mice were euthanized by cervical vertebra dislocation and then placed in 75% ethanol for 5 min twice. Immediately, the thymus gland and spleen were excised and weighed, and the thymus and spleen indices were calculated as the thymus weight/body weight and spleen weight/body weight, respectively.

Double femurs were removed under aseptic conditions, and bone marrow cells were flushed using sterile phosphate-buffered saline (PBS) to form a single cell suspension. The suspension was taken in a centrifuge tube and centrifuged for 10 min at 1200r/min. And, 2 mL of RBC lysis buffer was added, and it was let to stand for 3 minutes after blending centrifuged for 10 min at 1200r/min. The bone marrow karyocytes were removed and rinsed twice with 1 mL of sterile PBS for 10 min at 1200r/min and then resuspended in sterile PBS and counted using an inverted microscope.

2.5. Hematopoietic progenitor cells culture {#sec2.5}
-------------------------------------------

Bone marrow cells were plated at a concentration of 10^5^/mL on Iscove\'s Modified Dulbecco\'s Medium (IMDM) medium supplemented with horse serum, 10^−4^M 2-mercaptoethanol, 2 mM 3% L-glutamine, 20 ng/mL of recombinant mouse (rm) IL-3, 20 U/mL of recombinant human (rh) EPO, 50 ng/mL of rm granulocyte macrophage colony-stimulating factor (GM-CSF), and 5 ng/mL of rm TPO.

Plates were cultured at 37°C in 5% CO~2~ atmosphere. Colony-forming unit erythroid (CFU-E) were counted under inverted phase-contrast microscope after 3 days of culture. Burst-forming unit erythroid (BFU-E), colony-forming unit granulocyte macrophage (CFU-GM), and colony-forming unit megakaryocte (CFU-Meg) were counted after 7 days of culture.

2.6. Determination of the levels of GM-CSF, EPO, and TPO in plasma {#sec2.6}
------------------------------------------------------------------

Plasma samples were prepared from the blood samples collected from the mice, and the levels of EPO, TPO, GM-CSF, and IL-6 were measured by enzyme-linked immunosorbent assay.

2.7. Cell cycle {#sec2.7}
---------------

A single cell suspension was collected in a centrifuge tube, rinsed twice with cold PBS, and centrifuged, and then, 2 mL of 70% cold ethanol was added to fix the cells overnight at 4°C. Cells were then incubated with in the dark for 30 min. Cells from all groups were measured by flow cytometry.

2.8. Analysis of protein expressions of bal-2, bax, and caspase-3 in bone marrow cells {#sec2.8}
--------------------------------------------------------------------------------------

Western blotting is used for the determination of protein content. Total protein in BMNC was extracted, and protein concentration was determined by Bradford method. Protein samples were denatured and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) electrophoresis, transferred to Poly(vinylidene fluoride) (PVDF) membrane by semi-dry electrophoresis, and blocked using 5% skimmed milk liquid for 1 h, and primary antibodies were added and left undisturbed at 4°C overnight. After adding a secondary antibody (1:3000) and incubating for 1 hour, the color was developed by chemiluminescence. β-Actin was used as an internal reference. After the film was scanned, the protein bands were quantitatively analyzed, and the gray ratios of the target protein band and β-actin band were calculated as the relative expression level of each target protein.

2.9. Statistical analysis {#sec2.9}
-------------------------

The data were expressed as mean ± standard deviation. Statistical analysis was performed by one-way analysis of variance. Statistical analysis was performed using SPSS version 13.0 (SPSS, Chicago, IL, USA) statistical software, and *p* \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Effect of Re and Rk~3~ on peripheral blood cells in CTX-induced mice {#sec3.1}
-------------------------------------------------------------------------

The quantities of WBC, RBC, HGB, and PLT from peripheral blood are shown in [Table 1](#tbl1){ref-type="table"}. Compared with normal mice, the quantity of WBC increased (*p* \< 0.01), whereas RBC, HGB, and PLT decreased significantly (*p* \< 0.01) in the model group with CTX at a dose of 100 mg/kg. It also indicates that both Re and Rk~3~ can increase the quantities of HGB and PLT and decrease the quantity of WBC, whereas only Rk~3~-H can increase the quantity of RBC significantly (*p* \< 0.05). Two high-dose groups are more effective than two low-dose groups, and Rk~3~ is more effective than Re at any dose group.Table 1Effect of Re and Rk~3~ on peripheral blood cells in CTX-induced miceTable 1GroupsWBC (×10^9^/L)RBC (×10^12^/L)HGB (g/L)PLT (×10^9^/L)Normal7.30 ± 0.759.76 ± 0.27131.00 ± 4.59917.10 ± 74.65Model10.34 ± 1.40^\#\#^8.63 ± 0.68^\#\#^113.20 ± 6.66^\#\#^628.50 ± 66.09^\#\#^Positive8.47 ± 0.87^∗∗^9.46 ± 0.41^∗∗^126.70 ± 5.70^∗∗^881.10 ± 76.87^∗∗^Re-L9.40 ± 1.288.80 ± 0.58118.90 ± 8.67790.00 ± 97.66^∗∗^Re-H8.81 ± 0.89^∗∗^8.95 ± 0.75121.10 ± 6.31^∗∗^833.10 ± 68.04^∗∗^Rk~3~-L9.2 ± 1.29^∗^8.85 ± 1.02122.00 ± 5.29^∗∗^799.90 ± 72.21^∗∗^Rk~3~-H8.51 ± 0.97^∗∗^9.25 ± 0.59^∗^127.40 ± 3.92^∗∗a^853.60 ± 76.65^∗∗^[^2][^3][^4]

3.2. Effect of Re and Rk~3~ on the thymus/spleen index in CTX-induced mice {#sec3.2}
--------------------------------------------------------------------------

As shown in [Table 2](#tbl2){ref-type="table"}, compared with the normal group, the thymus index and spleen index of the mice in the model group changed significantly (*p* \< 0.01). The thymus index showed a decrease, and the spleen index is opposite to thymus index. Re and Rk~3~ can increase the thymus index significantly (*p* \< 0.01) while reduce the spleen index, but the effect on the spleen is not significant.Table 2Effects of Re and Rk~3~ on the thymus/spleen index in CTX-induced miceTable 2GroupsThymus index (mg/g)Spleen index (mg/g)Normal1.14 ± 0.144.02 ± 0.38Model0.28 ± 0.05^\#\#^8.94 ± 1.10^\#\#^Positive0.60 ± 0.08^∗∗^8.23 ± 1.36Re-L0.49 ± 0.06^∗∗^8.70 ± 0.86Re-H0.57 ± 0.07^∗∗^8.55 ± 0.96Rk~3~-L0.52 ± 0.07^∗∗^8.60 ± 1.64Rk~3~-H0.65 ± 0.09^∗∗a^8.25 ± 0.67[^5][^6][^7]

3.3. Effect of Re and Rk~3~ on the BMNC counts in CTX-induced mice {#sec3.3}
------------------------------------------------------------------

The quantity of BMNC was shown in [Fig. 1](#fig1){ref-type="fig"}. Compared with the mice in the normal group, the quantity of BMNC decreased significantly (*p* \< 0.01) in the model group. Both Re and Rk~3~ can increase the quantity of BMNC significantly (*p* \< 0.01) no matter high dose or low dose. We can also indicate that Rk~3~-H showed significant effects compared with the other three groups (*p* \< 0.05).Fig. 1Effect of Re and Rk~3~ on the BMNC count in CTX-induced mice. Data are expressed as mean ± SD (n = 6). ^\#\#^*p* \< 0.01 as compared with the normal group. ^∗∗^*p* \< 0.01 as compared with the model group. ^a^*p* \< 0.05 as compared with the Re-H group.BMNC, bone marrow nucleated cell; CTX, cyclophosphamide; SD, standard deviation.Fig. 1

3.4. Effect of Re and Rk~3~ on colony yield of hematopoietic progenitor cells *in vitro* in CTX-induced mice {#sec3.4}
------------------------------------------------------------------------------------------------------------

The yields of colony cultured *in vitro* were shown in [Fig. 2](#fig2){ref-type="fig"}. Compared with the mice in the normal group, the yields of CFU-GM, CFU-E, BFU-E, and CFU-Meg decreased significantly (*p* \< 0.01) in the model group. Rk~3~-H and Re-H can increase the yields significantly (*p* \< 0.01 or *p* \< 0.05), whereas the effect of Rk~3~-L and Re-L on colony is not significant.Fig. 2Effect of Re and Rk~3~ on colony yield of hematopoietic progenitor cells *in vitro* in CTX-induced mice. Data are expressed as mean ± SD (n = 6). ^\#\#^*p* \< 0.01 as compared with the normal group.^∗^*p* \< 0.05 as compared with the model group. ^∗∗^*p* \< 0.01 as compared with the model group. ^a^*p* \< 0.05 as compared with the Re-H group.BFU-E, Burst-forming unit erythroid; CFU-E, Colony-forming unit erythroid; CFU-GM, colony-forming unit granulocyte macrophage; CFU-Meg, colony-forming unit megakaryocte; CTX, cyclophosphamide; SD, standard deviation.Fig. 2

3.5. Effect of Re and Rk~3~ on the hematopoiesis-related cytokines in CTX-induced mice {#sec3.5}
--------------------------------------------------------------------------------------

As shown in [Fig. 3](#fig3){ref-type="fig"}, compared to the normal group, the level of GM-CSF and TPO in the model group increased significantly (*p* \< 0.01). Both Rk~3~-H and Re-H can decrease the level of TPO significantly (*p* \< 0.01 or *p* \< 0.05). Only Rk~3~-H can decrease the level of GM-CSF significantly (*p* \< 0.01).The differences between these 7 groups on the level of EPO are all not significantly.Fig. 3Effect of Re and Rk~3~ on the hematopoiesis-related cytokines (A) GM-CSF, (B) EPO, and (C) TPO in CTX-induced mice. Data are expressed as mean ± SD (n = 10). ^\#\#^*p* \< 0.01 as compared with the normal group.^∗^*p* \< 0.05 as compared with the model group. ^∗∗^*p* \< 0.01 as compared with the model group. ^a^*p* \< 0.05 as compared with the Re-H group.CTX, cyclophosphamide; EPO, erythropoietin; GM-CSF, granulocyte macrophage colony-stimulating factor; SD, standard deviation; TPO, thrombopoietin.Fig. 3

3.6. Effect of Re and Rk~3~ on cell cycle in CTX-induced mice {#sec3.6}
-------------------------------------------------------------

The ratios of every phase were shown in [Fig. 4](#fig4){ref-type="fig"}. The ratio of G~0~/G~1~ phase in the model group was significantly higher than that in the normal group (*p* \< 0.01). At the same time, the ratios of S phase and G~2~/M phase are significantly lower (*p* \< 0.01). Both Re and Rk~3~ can decrease the ratio of G~0~/G~1~ phase and increase the ratios of S phase significantly (*p* \< 0.01 or *p* \< 0.05). Only Rk~3~-H can increase the ratios of G~2~/M phase significantly (*p* \< 0.05).Fig. 4Effect of Re and Rk~3~ on cell cycle in CTX-induced mice. Data are expressed as mean ± SD (n = 6). ^\#\#^*p* \< 0.01 as compared with the normal group. ^∗^*p* \< 0.05 as compared with the model group. ^∗∗^*p* \< 0.01 as compared with the model group.CTX, cyclophosphamide; SD, standard deviation.Fig. 4

3.7. Effect of Re and Rk~3~ on protein expressions of bcl-2, bax, and caspase-3 in bone marrow cell in CTX-induced mice {#sec3.7}
-----------------------------------------------------------------------------------------------------------------------

The expressions of bcl-2, bax, and caspase-3 were shown in [Fig. 5](#fig5){ref-type="fig"}. Compared with the normal group, the expression of bcl-2 decreased significantly (*p* \< 0.05), whereas the expression of bax and caspase-3 increased significantly (*p* \< 0.05) in the bone marrow cells of the mice from the model group. Both Re and Rk~3~ can increase the expression of bcl-2 and decrease the expression of bax and caspase-3 significantly (*p* \< 0.01 or *p* \< 0.05). The effect of Rk~3~ is better than Re significantly (*p* \< 0.05) on bcl-2 and bax while not significantly on caspase-3.Fig. 5Effect of Re and Rk~3~ on protein expressions of (A) bcl-2, (B) bax, (C) bcl-2/bax, and (D) caspase-3 in bone marrow cell in CTX-induced mice. Data are expressed as mean ± SD (n = 3). ^\#\#^*p* \< 0.01 as compared with the normal group. ^∗∗^*p* \< 0.01 as compared with the model group. ^a^*p* \< 0.05 as compared with the Re-H group.CTX, cyclophosphamide; SD, standard deviation.Fig. 5

4. Discussion {#sec4}
=============

CTX is one of the most commonly used alkylating cytotoxic chemotherapeutic agents [@bib16]. It can directly damage intracellular DNA molecules [@bib17], affect cell division, and can also induce senescence and apoptosis of hematopoietic stem cells [@bib18], [@bib19]. Owing to the lack of specificity, while killing and damaging tumor cells, CTX also affects the hematopoietic precursor stem cells [@bib20], [@bib21]. In this study, the model of mice with myelosuppression was established by i.p. injection of CTX. After injection, as same as the clinical symptoms of myelosuppression, the mice showed signs of reduced diet, weight loss, diarrhea, mass hair loss, and fatigue.

Myelosuppression appears as a decrease in the number of various types of blood cells in the peripheral blood [@bib22]. Therefore, the number of WBC, RBC, HGB, and PLT from peripheral blood can directly reflect the degree of myelosuppression. The number of WBC changes most obviously because of its short life cycle [@bib23]. The number of WBC in the mice from the model group was significantly higher than that of mice from the normal group. Some cell stores in bone marrow may be mobilized into the peripheral blood quickly after the WBC death caused by CTX. This should be the rebound of WBC [@bib24] because these cells do not have a sound function just like WBC, but only the body\'s stress response to the loss of WBC. So they have no immune function. WBC will decrease rapidly after rebound which was proved in our preliminary experiments. The increase of WBC in the mice from the administration group was smaller than that from the model group. We speculated that the Re and Rk~3~ can improve myelosuppression to a certain extent, which reduces the degree of stress response in WBC. Thrombocytopenia can cause bleeding, while severe reduction can even lead to death. The number of PLT in the mice from the model group was significantly lower than that of mice from the normal group. PLT life cycle may become shorter because of the damage of megakaryocyte. The number of PLT in mice from the administration group increased. It shows that Re and Rk~3~ can promote recovery the bone marrow hematopoietic function.

The number of BMNCs is a direct indicator of bone marrow hematopoietic function [@bib24]. The decrease in the number of BMNC in the model group indicates that CTX may cause acute damage of bone marrow and induce senescence and apoptosis of BMNC. The damage is somewhat alleviated after administration. The thymus index and spleen index were also investigated in the present study because of the close relationship between immunity and hematopoiesis [@bib24]. The thymus is an important immune organ [@bib25]. The maturation of lymphocytes also depends on the thymus [@bib26]. Thymus and thymocytes not only provide a specific microenvironment but also secrete important cytokines [@bib27]. The thymus index of mice from the model group decreased significantly. The damage of immune organs may be caused by apoptosis of thymocytes due to CTX. The increase of thymus index indicates that the Re and Rk~3~ can promote the recovery of this damage after administration. Spleen is not only a hematopoietic organ but also an immune organ [@bib28]. The spleen can restore hematopoiesis and perform compensatory extramedullary hematopoiesis when the function of bone marrow is damaged [@bib29]. The increase of spleen index in mice from the model group indicates that while CTX causes bone marrow hematopoietic damage in mice, spleen compensatory hematopoiesis leads to spleen connective tissue hyperplasia. The spleen index of the mice from the administration group is smaller than that of the model group. We speculate that Re and Rk~3~ may reduce the burden of the spleen while restoring bone marrow hematopoietic function [@bib30].

To further explore the mechanism of Re and Rk~3~ in improving hematopoietic function, we analyzed the effect on colony yield of hematopoietic progenitor cells *in vitro*; the effect on TPO, EPO, and GM-CSF of plasma; and the effect on cell cycle and the expression of bcl-2, bax, and caspase-3 proteins.

The essence of myelosuppression is that the function of hematopoietic stem cell/hematopoietic progenitor cell (HSC/HPC) in the bone marrow is impaired after chemotherapy [@bib31]. The yield of colony cultured *in vitro* can be used to evaluate the function of HSC/HPC. The yield of BFU-E, CFU-E, CFU-Meg, and CFU-GM is lower in the mice from the model group. It showed that CTX can cause serious damage to the proliferation and differentiation of HPC. The yield of colony in the mice from the administration group was more than that in the model group significantly. We speculate that Re and Rk~3~ may increase the sensitivity of the receptor on the cell surface that binds to the cytokines and enhance the proliferation and differentiation of HPC. The quantity of bone marrow cells that have been reduced by the damage of CTX is recovered so that the peripheral blood can restore.

Cytokines are important factors to stimulate the proliferation and differentiation of HSC/HPC [@bib32]. GM-CSF has stimulative effect of the proliferation and differentiation on the process from myeloid stem cells to mature granulocytes [@bib33]. The main physiological function of EPO is promoting the binding of erythroid progenitor cells\' surface receptor, acceleration erythroid stem cells differentiate into erythrocytes and synthesis of HGB [@bib34], [@bib35]. TPO can boost HSC differentiation to megakaryocytes, stimulate the development and maturity of megakaryocytes, and gear up the production and release of PLT [@bib36]. When HSC activity weakens, the number of these cytokines will be forced to rise. This is a reflection of the body\'s compensation mechanism [@bib37]. Our results show that both Re and Rk~3~ make the number of GM-CSF, EPO, and TPO normal, indirectly demonstrating the recovery of hematopoietic stem cells\' proliferative and differentiative capacity.

The cell cycle of bone marrow is one of the important indicators reflecting the hematopoietic function of the hematopoietic system, and the distribution of the various phases of the cell cycle can reflect the state of bone marrow cell proliferation [@bib38]. The ratio of G~0~/G~1~ phase in the model group was significantly higher than that in the normal group, indicating the CTX-induced DNA damage in hematopoietic cells and that the damaged DNA stayed in G~1~ phase to repair. And, for DNA that cannot be repaired, an apoptotic program will be initiated. This process leads to a reduction in the ratio of cells in the S and G~2~/M phase and the proliferation index. The ratio of G~0~/G~1~ phase in the mice in the administration group was significantly lower than that in the model group. We speculate that Re and Rk~3~ may facilitate the repair of damaged DNA and may also arouse part of cells in G~0~ phase. Therefore, more cells can pass the G~1~ phase checkpoint to enter the S phase for DNA synthesis and then enter the G~2~/M phase to complete mitosis. Re and Rk~3~ can antagonize the toxicity and side effects of CTX on bone marrow cells effectively.

Bcl-2 protein (bcl-2) can inhibit many types of apoptosis. It protects cells by prolonging the survival time of cells so that it can provide time for the repair of DNA that was damaged before cell division [@bib39]. Bax protein (bax) has the opposite biological function as bcl-2. Bax can promote apoptosis by increasing the sensitivity of apoptosis [@bib40]. Caspase-3 protein (caspase-3) is a common downstream effector of the various apoptosis pathway [@bib41]. It is an apoptotic executant that occupies the core position in the whole process of apoptosis [@bib42]. It is considered a very specific and sensitive apoptotic marker [@bib43]. The results show that Re and Rk~3~ can stimulate the expression of bcl-2 and inhibit the expression of bax and caspase-3. Regulating the balance of bcl-2/bax and inhibiting the expression of caspase-3 may be one of the mechanisms of Re and Rk~3~ in promoting myeloid bone marrow cell proliferation and recovering bone marrow hematopoietic function in mice.

5. Conclusion {#sec5}
=============

In conclusion, the present study demonstrates that Re and Rk~3~ could relieve the symptoms of myelosuppression and improve the bone marrow hematopoietic function. It is probably attributed to three different mechanisms. First, Re and Rk~3~ could regulate the level of cytokines to normal. Second, Re and Rk~3~ could promote more cells to pass the G~1~ phase checkpoint to enter the normal cell cycle. Third, Re and Rk~3~ could regulate the balance of bcl-2/bax and inhibit the expression of caspase-3 to prevent BMNC from apoptosis. Our results showed that Rk~3~ in both low and high concentrations was significantly effective compared with Re. It may be due to its lower polarity, greater lipid solubility, and ease to pass through biofilms. The present study provided an experimental basis for the treatment of myelosuppression and the development of Re and Rk~3~. Furthermore, more precise mechanisms will be investigated in the subsequent research.
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